Exact Sciences (NASDAQ:EXAS) PT Raised to $88.00

Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective increased by Bank of America from $80.00 to $88.00 in a research note published on Wednesday, The Fly reports. EXAS has been the subject of several other reports. Raymond James downgraded shares of Exact Sciences from an outperform rating to a market perform rating in […]

Related Keywords

United States ,America ,Jeffrey Thomas Elliott ,Raymond James ,Sarah Condella ,Sciences Corp ,Oppenheimer Co ,Sciences Company Profile ,Analyst Recommendations For Exact Sciences ,Sciences Stock Performance ,Advisor Group ,Nasdaq ,News Ratings For Exact Sciences Daily ,Atria Investments Inc ,Insider Transactions At Exact Sciences ,Register Financial Advisors ,Citigroup ,Sohn Co ,Exact Sciences ,Get Rating ,Moderate Buy ,Thomas Elliott ,Investments Inc ,Financial Advisors ,Exact Sciences Daily ,Nasdaq Exas ,Texas ,Medical ,30063p10 ,Boost Price Target ,Bank Of America Co ,